Xiaochen Wang
Welcome,         Profile    Billing    Logout  
 0 Trials 
5 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Wang, Xiaochen
NCT05577312: Safety and Efficacy Evaluation of BRL-101 in Subjects With Transfusion-Dependent β-Thalassemia

Enrolling by invitation
1
9
RoW
BRL-101, BRL-101 autologous hematopoietic stem and progenitor cells injection
Bioray Laboratories, First Affiliated Hospital of Guangxi Medical University, Xiangya Hospital of Central South University, Chinese Academy of Medical Sciences, Nanfang Hospital, Southern Medical University
Beta-Thalassemia
08/25
09/26
NCT06314529: Long-term Follow-up Study of BHC001 for TDT

Recruiting
N/A
6
RoW
Assessments
Bioray Laboratories, The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army, Xiangya Hospital of Central South University
Thalassemia, Beta
12/36
05/37
NCT06671249: Comparing the Safety and Cosmetic Outcomes Between Laparoscopic Versus Traditional Open Breast-conserving Surgery

Not yet recruiting
N/A
184
RoW
Laparoscopic breast-conserving surgery, Traditional open breast-conserving surgery
Second Affiliated Hospital, School of Medicine, Zhejiang University
Breast Cancer
05/27
10/27
NCT06298630: Long-term Follow-up Study of BRL-101 for TDT

Not yet recruiting
N/A
45
RoW
Assessments
Bioray Laboratories, First Affiliated Hospital of Guangxi Medical University, Xiangya Hospital of Central South University, Chinese Academy of Medical Sciences, Nanfang Hospital, Southern Medical University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army, Shenzhen Children 's Hospital
Thalassemia, Beta
08/38
10/38
NCT05731258: Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen

Recruiting
N/A
150
RoW
Liposomal doxorubicin containing regimen
Second Affiliated Hospital, School of Medicine, Zhejiang University
Breast Cancer, Liposomal Doxorubicin, Efficacy, Safety, Postoperative Adjuvant Treatment
10/27
10/32

Download Options